Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma

Journal of Thoracic Oncology

Volumn 8, Issue 4, 2013, Pages 478-486

  Labby, Zacariah E ^a   Armato, Samuel G ^a   Dignam, James J ^a   Straus, Christopher ^a   Kindler, Hedy L ^a   Nowak, Anna K ^b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Chest CT; Malignant pleural mesothelioma; Therapy response assessment

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; CISPLATIN; GEMCITABINE; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 84875397758     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31828354c8     Document Type: Article

References (31)

1. Francis RJ, Byrne MJ, van der Schaaf AA, et al. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med 2007;48:1449-1458
2. Lee HY, Hyun SH, Lee KS, et al. Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: Prediction of therapeutic response and prognostic implications. Ann Surg Oncol 2010;17:2787-2794
3. Nowak AK, Francis RJ, Phillips MJ, et al. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clin Cancer Res 2010;16:2409-2417
4. Jaffe CC. Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 2006;24:3245-3251
5. Prasad SR, Jhaveri KS, Saini S, Hahn PF, Halpern EF, Sumner JE. CT tumor measurement for therapeutic response assessment: Comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 2002;225:416-419
6. Boone JM. Radiological interpretation 2020: Toward quantitative image assessment. Med Phys 2007;34:4173-4179
7. Michaelis LC, Ratain MJ. Measuring response in a post-RECIST world from black and white to shades of grey. Nat Rev Cancer 2006;6:409-414
8. Mehrara E, Forssell-Aronsson E, Bernhardt P. Objective assessment of tumour response to therapy based on tumour growth kinetics. Br J Cancer 2011;105:682-686
9. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216
10. Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: A review of validation studies on tumour assessment. Eur J Cancer 2006;42:1031-1039
11. Oxnard GR, Armato SG 3rd, Kindler HL. Modeling of mesothelioma growth demonstrates weaknesses of current response criteria. Lung Cancer 2006;52:141-148
12. Corson N, Sensakovic WF, Straus C, Starkey A, Armato III S.G. Characterization of mesothelioma and tissues present in contrastenhanced thoracic CT scans. Med Phys 2011;38:942-947
13. Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004;15:257-260
14. Frauenfelder T, Tutic M, Weder W, et al. Volumetry: An alternative to assess therapy response for malignant pleural mesothelioma? Eur Respir J 2011;38:162-168
15. Pass HI, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1998;115:310-317; discussion 317
16. Liu F, Zhao B, Krug LM, et al. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computeraided volumetric measurement on computed tomography scans. J Thorac Oncol 2010;5:879-884
17. Sensakovic WF, Armato SG 3rd, Starkey A, Kindler HL, Vigneswaran WT. Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy/decortication. Acad Radiol 2011;18:294-298
18. Armato SG 3rd, Oxnard GR, Kocherginsky M, Vogelzang NJ, Kindler HL, MacMahon H. Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans. Acad Radiol 2005;12:1301-1309
19. Sensakovic WF, Armato SG 3rd, Straus C, et al. Computerized segmentation and measurement of malignant pleural mesothelioma. Med Phys 2011;38:238-244
20. Armato SG 3rd, Sensakovic WF. Automated lung segmentation for thoracic CT impact on computer-Aided diagnosis. Acad Radiol 2004;11:1011-1021
21. Labby ZE, Nowak AK, Dignam JJ, Straus C, Kindler HL, Armato III S.G. Disease volumes as a marker for patient response in malignant pleural mesothelioma. Ann Oncol November 8, 2012. [Epub ahead of print
22. Sensakovic WF, Starkey A, Roberts RY, Armato III S.G. Discrete-space versus continuous-space lesion boundary and area definitions. Med Phys 2008;35:4070-4078
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310
24. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. 2nd Ed. New York, NY: Springer, 2010
25. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220
26. Zhou M. Understanding the Cox regression models with time-change covariates. Am Stat 2001;55:153-155
27. Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 2005;61:92-105
28. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2011
29. Labby ZE, Armato SG 3rd, Kindler HL, Dignam JJ, Hasani A, Nowak AK. Optimization of response classification criteria for patients with malignant pleural mesothelioma. J Thorac Oncol 2012;7:1728-1734
30. Armato SG 3rd, Oxnard GR, MacMahon H, et al. Measurement of mesothelioma on thoracic CT scans: A comparison of manual and computerassisted techniques. Med Phys 2004;31:1105-1115
31. Armato SG 3rd, Ogarek JL, Starkey A, et al. Variability in mesothelioma tumor response classification. AJR Am J Roentgenol 2006;186 1000-1006